Trial intelligence / Profile preview

Fibrasic: Sirolimus vs Cyclosporine in Renal Transplant

NCT00493194Phase 4Unknown

Start
May 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of sirolimus in kidney transplantation (2 arms). Primary endpoint: Cortical fractional interstitial fibrosis volume at 6 months. Status: unknown.

02

Drugs

sirolimus
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT00493194.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00493194.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call